Press Releases Year: - Any -20192018201720162015201420132012201120102009 Nov 27, 2017 Summary ToggleOtonomy Announces Plan to Focus Resources on Development Programs Nov 22, 2017 Summary ToggleOtonomy to Present at Piper Jaffray Healthcare Conference Nov 08, 2017 Summary ToggleOtonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update Nov 08, 2017 Summary ToggleOtonomy Reports Positive Results from AVERTS-2 Phase 3 Trial of OTIVIDEX™ in Patients with Ménière's Disease Nov 01, 2017 Summary ToggleOtonomy to Report Third Quarter 2017 Financial Results and Provide Corporate Update Sep 13, 2017 Summary ToggleOtonomy Provides Business and Financial Update Aug 30, 2017 Summary ToggleOtonomy Reports Results for AVERTS-1 Phase 3 Trial for OTIVIDEX™ in Patients with Ménière's Disease Aug 03, 2017 Summary ToggleOtonomy Reports Second Quarter 2017 Financial Results and Provides Corporate Update Jul 27, 2017 Summary ToggleOtonomy to Report Second Quarter 2017 Financial Results and Provide Corporate Update Jul 18, 2017 Summary ToggleOtonomy Announces FDA Acceptance of OTIPRIO® Supplemental New Drug Application Filing for Acute Otitis Externa Jun 22, 2017 Summary ToggleOtonomy Announces Successful End-of-Phase 2 Review by FDA for OTIPRIO® in Acute Otitis Media with Tympanostomy Tubes Jun 20, 2017 Summary ToggleOtonomy to Host Key Opinion Leader Meeting for Investors on Ménière's Disease May 12, 2017 Summary ToggleOtonomy Announces OTIPRIO® Data Presentation and Symposium at the American Society of Pediatric Otolaryngology Annual Meeting May 10, 2017 Summary ToggleOtonomy to Present at the Bank of America Merrill Lynch Health Care Conference May 04, 2017 Summary ToggleOtonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update Apr 27, 2017 Summary ToggleOtonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update Mar 02, 2017 Summary ToggleOtonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update Feb 28, 2017 Summary ToggleOtonomy to Present at Cowen and Company Health Care Conference Feb 24, 2017 Summary ToggleOtonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update Jan 19, 2017 Summary ToggleOtonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss Jan 09, 2017 Summary ToggleOtonomy Provides Corporate and Product Pipeline Update Jan 05, 2017 Summary ToggleOtonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa Jan 03, 2017 Summary ToggleOtonomy to Present at the J.P. Morgan Healthcare Conference
Press Releases Year: - Any -20192018201720162015201420132012201120102009 Nov 27, 2017 Summary ToggleOtonomy Announces Plan to Focus Resources on Development Programs Nov 22, 2017 Summary ToggleOtonomy to Present at Piper Jaffray Healthcare Conference Nov 08, 2017 Summary ToggleOtonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update Nov 08, 2017 Summary ToggleOtonomy Reports Positive Results from AVERTS-2 Phase 3 Trial of OTIVIDEX™ in Patients with Ménière's Disease Nov 01, 2017 Summary ToggleOtonomy to Report Third Quarter 2017 Financial Results and Provide Corporate Update Sep 13, 2017 Summary ToggleOtonomy Provides Business and Financial Update Aug 30, 2017 Summary ToggleOtonomy Reports Results for AVERTS-1 Phase 3 Trial for OTIVIDEX™ in Patients with Ménière's Disease Aug 03, 2017 Summary ToggleOtonomy Reports Second Quarter 2017 Financial Results and Provides Corporate Update Jul 27, 2017 Summary ToggleOtonomy to Report Second Quarter 2017 Financial Results and Provide Corporate Update Jul 18, 2017 Summary ToggleOtonomy Announces FDA Acceptance of OTIPRIO® Supplemental New Drug Application Filing for Acute Otitis Externa Jun 22, 2017 Summary ToggleOtonomy Announces Successful End-of-Phase 2 Review by FDA for OTIPRIO® in Acute Otitis Media with Tympanostomy Tubes Jun 20, 2017 Summary ToggleOtonomy to Host Key Opinion Leader Meeting for Investors on Ménière's Disease May 12, 2017 Summary ToggleOtonomy Announces OTIPRIO® Data Presentation and Symposium at the American Society of Pediatric Otolaryngology Annual Meeting May 10, 2017 Summary ToggleOtonomy to Present at the Bank of America Merrill Lynch Health Care Conference May 04, 2017 Summary ToggleOtonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update Apr 27, 2017 Summary ToggleOtonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update Mar 02, 2017 Summary ToggleOtonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update Feb 28, 2017 Summary ToggleOtonomy to Present at Cowen and Company Health Care Conference Feb 24, 2017 Summary ToggleOtonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update Jan 19, 2017 Summary ToggleOtonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss Jan 09, 2017 Summary ToggleOtonomy Provides Corporate and Product Pipeline Update Jan 05, 2017 Summary ToggleOtonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa Jan 03, 2017 Summary ToggleOtonomy to Present at the J.P. Morgan Healthcare Conference
